HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use INFLECTRA safely and effectively. See full prescribing information for INFLECTRA.
INFLECTRA® (infliximab-dyyb) for injection, for intravenous use
Initial U.S. Approval: 2016
INFLECTRA (infliximab-dyyb) is biosimilar1 to REMICADE (infliximab)
WARNING: SERIOUS INFECTIONS and MALIGNANCY
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.